Pharmaceutical News and Articles

FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections

People's Brains Now Process Texts Almost as Quickly as Pictures

like whether to keep or delete an email or how to respond to a brief social media update, Pylkkanen explained. But how well do we really understand these quick

Wildfires Are Gaining Speed in Western U.S., Upping Threat to People

those that expanded by more than 4,000 acres per day. They found that these fast fires have increased by more than 250 over the past two decades across the West

CDC Says Some People May Need Extra Dose of COVID Vaccine

we now have the green light to give it to them, in no uncertain terms, Dr. William Schaffner, an infectious disease specialist at Vanderbilt University Medical

CDC Confirms Second Human Bird Flu Case in Missouri With No Known Exposure to Farm Animals

A second person in Missouri who wasn t exposed to either poultry or dairy cows has been infected with bird flu, U.S. health officials reported Thursday.This per

Burger King, Other Fast Food Chains Also Pulling Onions Tied to E. Coli Outbreak

With onions from one supplier implicated as the source of E. coli illness linked to McDonald s Quarter Pounders, other fast food chains are now pulling the onio

U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for Adults Aged 18 to 59 at Increased Risk for Disease

FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy

Omeros Corporation today announced that zaltenibart (OMS906) has received rare pediatric disease designation from the U.S. Food and Drug Administration (FDA) fo

Botox Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)

Infectious Diseases Society of America, Oct. 16-19

From 1999 to 2019, there was a decrease in the sepsis-related mortality rate in children overall and across demographic groups, according to findings presented